C C Land Holdings Limited (HKG:1224)

Revance Therapeutics Statistics

Total Valuation

HKG:1224 has a market cap or net worth of HKD 4.62 billion. The enterprise value is 12.64 billion.

Market Cap	4.62B
Enterprise Value	12.64B

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1224 has 3.88 billion shares outstanding.

Current Share Class	3.88B
Shares Outstanding	3.88B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	73.97%
Owned by Institutions (%)	1.08%
Float	1.01B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.09
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.46
EV / Sales	24.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.73

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.81.

Current Ratio	0.86
Quick Ratio	0.69
Debt / Equity	0.81
Debt / EBITDA	67.50
Debt / FCF	-22.73
Interest Coverage	0.20

Financial Efficiency

Return on equity (ROE) is -4.70% and return on invested capital (ROIC) is 0.33%.

Return on Equity (ROE)	-4.70%
Return on Assets (ROA)	0.32%
Return on Invested Capital (ROIC)	0.33%
Return on Capital Employed (ROCE)	0.63%
Revenue Per Employee	4.84M
Profits Per Employee	-5.88M
Employee Count	105
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:1224 has paid 22.34 million in taxes.

Income Tax	22.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.83% in the last 52 weeks. The beta is 0.23, so HKG:1224's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+0.83%
50-Day Moving Average	1.20
200-Day Moving Average	1.20
Relative Strength Index (RSI)	60.61
Average Volume (20 Days)	71,790

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1224 had revenue of HKD 508.32 million and -617.92 million in losses. Loss per share was -0.16.

Revenue	508.32M
Gross Profit	471.06M
Operating Income	125.99M
Pretax Income	-595.58M
Net Income	-617.92M
EBITDA	139.44M
EBIT	125.99M
Loss Per Share	-0.16

Balance Sheet

The company has 2.34 billion in cash and 10.36 billion in debt, giving a net cash position of -8.02 billion or -2.07 per share.

Cash & Cash Equivalents	2.34B
Total Debt	10.36B
Net Cash	-8.02B
Net Cash Per Share	-2.07
Equity (Book Value)	12.79B
Book Value Per Share	3.29
Working Capital	-482.31M

Cash Flow

In the last 12 months, operating cash flow was -455.86 million and capital expenditures -121,000, giving a free cash flow of -455.99 million.

Operating Cash Flow	-455.86M
Capital Expenditures	-121,000
Free Cash Flow	-455.99M
FCF Per Share	-0.12

Margins

Gross margin is 92.67%, with operating and profit margins of 24.79% and -121.56%.

Gross Margin	92.67%
Operating Margin	24.79%
Pretax Margin	-117.17%
Profit Margin	-121.56%
EBITDA Margin	27.43%
EBIT Margin	24.79%
FCF Margin	n/a

Dividends & Yields

HKG:1224 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.38%
FCF Yield	-9.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 11, 2007. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 11, 2007
Split Type	Reverse
Split Ratio	0.1

Scores

HKG:1224 has an Altman Z-Score of 0.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.33
Piotroski F-Score	4